Nationwide cost-effectiveness analysis of surgical stabilization of rib fractures by flail chest status and age groups

连枷胸 医学 外科 决策分析 质量调整寿命年 成本效益分析 成本效益 风险分析(工程) 生态学 数学 生物 统计
作者
Jeff Choi,Bianca Mulaney,Wasin Laohavinij,Richard Trimble,Lakshika Tennakoon,David A. Spain,Joshua A. Salomon,Jeremy D. Goldhaber‐Fiebert,Joseph D. Forrester
出处
期刊:The journal of trauma and acute care surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:90 (3): 451-458 被引量:17
标识
DOI:10.1097/ta.0000000000003021
摘要

Surgical stabilization of rib fracture (SSRF) is increasingly used to manage patients with rib fractures. Benefits of performing SSRF appear variable, and the procedure is costly, necessitating cost-effectiveness analysis for distinct subgroups. We aimed to assess the cost-effectiveness of SSRF versus nonoperative management among patients with rib fractures younger than 65 years versus 65 years or older, with versus without flail chest. We hypothesized that, compared with nonoperative management, SSRF is cost-effective only for patients with flail chest.This economic evaluation used a decision-analytic Markov model with a lifetime time horizon incorporating US population-representative inputs to simulate benefits and risks of SSRF compared with nonoperative management. We report quality-adjusted life years (QALYs), costs, and incremental cost-effectiveness ratios. Deterministic and probabilistic sensitivity analyses accounted for most plausible clinical scenarios.Compared with nonoperative management, SSRF was cost-effective for patients with flail chest at willingness-to-pay threshold of US $150,000/QALY gained. Surgical stabilization of rib fracture costs US $25,338 and US $123,377/QALY gained for those with flail chest younger than 65 years and 65 years or older, respectively. Surgical stabilization of rib fracture was not cost-effective for patients without flail chest, costing US $172,704 and US $243,758/QALY gained for those younger than 65 years and 65 years or older, respectively. One-way sensitivity analyses showed that, under most plausible scenarios, SSRF remained cost-effective for subgroups with flail chest, and nonoperative management remained cost-effective for patients older than 65 years without flail chest. Probability that SSRF is cost-effective ranged from 98% among patients younger than 65 years with flail chest to 35% among patients 65 years or older without flail chest.Surgical stabilization of rib fracture is cost-effective for patients with flail chest. Surgical stabilization of rib fracture may be cost-effective in some patients without flail chest, but delineating these patients requires further study.Economic/decision, level II.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
搜集达人应助吃猫的鱼采纳,获得10
刚刚
顾矜应助疯狂的芒果采纳,获得10
1秒前
1秒前
yj完成签到 ,获得积分10
1秒前
1秒前
vidgers完成签到 ,获得积分10
2秒前
msk完成签到,获得积分10
3秒前
tinanao完成签到,获得积分10
3秒前
Jasper应助傅双庆采纳,获得10
5秒前
舒适含之发布了新的文献求助10
5秒前
提莫蘑菇完成签到,获得积分20
5秒前
Issac完成签到,获得积分20
5秒前
冰酒发布了新的文献求助10
5秒前
跳跃仙人掌应助meethaha采纳,获得20
6秒前
6秒前
7秒前
foregan完成签到,获得积分10
7秒前
zkz发布了新的文献求助10
7秒前
wy123完成签到 ,获得积分10
7秒前
Onetwothree完成签到 ,获得积分10
8秒前
NexusExplorer应助木cheng采纳,获得10
9秒前
9秒前
9秒前
wly9399375发布了新的文献求助10
11秒前
11秒前
11秒前
11秒前
快乐慕灵完成签到,获得积分10
12秒前
qujunming完成签到 ,获得积分10
12秒前
heiyi完成签到,获得积分10
13秒前
13秒前
我不爱池鱼应助Darsine采纳,获得10
13秒前
越学越精神完成签到,获得积分10
14秒前
imemorizedpi发布了新的文献求助10
14秒前
鲨鱼要吃肉完成签到 ,获得积分10
14秒前
小一完成签到,获得积分20
15秒前
Xixia完成签到,获得积分10
15秒前
16秒前
GAJ完成签到,获得积分10
16秒前
高分求助中
Impact of Mitophagy-Related Genes on the Diagnosis and Development of Esophageal Squamous Cell Carcinoma via Single-Cell RNA-seq Analysis and Machine Learning Algorithms 2000
Evolution 1100
How to Create Beauty: De Lairesse on the Theory and Practice of Making Art 1000
Research Methods for Sports Studies 1000
Gerard de Lairesse : an artist between stage and studio 670
T/CAB 0344-2024 重组人源化胶原蛋白内毒素去除方法 500
[Procedures for improving absorption properties of polystyrene microtest plates by coating with nitrocellulose] 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 2981044
求助须知:如何正确求助?哪些是违规求助? 2642395
关于积分的说明 7129843
捐赠科研通 2275388
什么是DOI,文献DOI怎么找? 1207065
版权声明 592045
科研通“疑难数据库(出版商)”最低求助积分说明 589680